Physician profile
Laura Moore
NPI 1104215987
$50,120.43
in general payments reported to CMS, 2019-2025
8 companies · $971 in 2025
The $971 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $7,080 · 2022: $35K · 2023: $7,113 · 2024: $278 · 2025: $971.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,000 · Food and Beverage: $789 · Travel and Lodging: $573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,000.00 |
| Food and Beverage | $789.28 |
| Travel and Lodging | $572.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $28,138.38 | 2021-2025 | Bone Anchors With Arthroscopic Delivery System |
| Arthrex, INC. | $20,678.34 | 2022 | |
| Medical Device Business Services, INC. | $638.48 | 2025 | Healix Knotless Peek |
| Osteoremedies, LLC | $194.30 | 2025 | Biowash Surgical Irrigation, Osteoboost Select 5cc, Remedy Spectrum Gv Spacer |
| Exactech, INC. | $192.58 | 2021-2023 | |
| Linvatec Corporation | $130.85 | 2024 | Biobrace 23mm |
| Revance Therapeutics, INC. | $100.40 | 2024 | Daxxify |
| Stryker Corporation | $47.10 | 2024 | Blueprint Patient Specific Instrumentation |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.